TD Asset Management’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-43,400
| Closed | -$256K | – | 1283 |
|
|
2024
Q3 | $256K | Buy |
+43,400
| New | +$256K | ﹤0.01% | 1351 |
|
|
2024
Q2 | – | Sell |
-92,800
| Closed | -$758K | – | 1377 |
|
|
2024
Q1 | $758K | Sell |
92,800
-1,600
| -2% | -$13.1K | ﹤0.01% | 1227 |
|
|
2023
Q4 | $533K | Buy |
+94,400
| New | +$533K | ﹤0.01% | 1291 |
|
|
2023
Q3 | – | Sell |
-48,453
| Closed | -$133K | – | 1418 |
|
|
2023
Q2 | $133K | Hold |
48,453
| – | – | ﹤0.01% | 1381 |
|
|
2023
Q1 | $152K | Hold |
48,453
| – | – | ﹤0.01% | 1391 |
|
|
2022
Q4 | $286K | Hold |
48,453
| – | – | ﹤0.01% | 1364 |
|
|
2022
Q3 | $414K | Sell |
48,453
-6,700
| -12% | -$57.2K | ﹤0.01% | 1327 |
|
|
2022
Q2 | $416K | Sell |
55,153
-52,000
| -49% | -$392K | ﹤0.01% | 1318 |
|
|
2022
Q1 | $2.6M | Buy |
107,153
+800
| +0.8% | +$19.4K | ﹤0.01% | 1005 |
|
|
2021
Q4 | $3.43M | Buy |
106,353
+6,600
| +7% | +$213K | ﹤0.01% | 980 |
|
|
2021
Q3 | $4.46M | Buy |
99,753
+3,900
| +4% | +$174K | ﹤0.01% | 846 |
|
|
2021
Q2 | $4.14M | Buy |
95,853
+29,300
| +44% | +$1.26M | ﹤0.01% | 880 |
|
|
2021
Q1 | $2.46M | Buy |
66,553
+50,772
| +322% | +$1.88M | ﹤0.01% | 1056 |
|
|
2020
Q4 | $523K | Buy |
+15,781
| New | +$523K | ﹤0.01% | 1326 |
|